Measles virus antigens in breast cancer

Anticancer Research

Volumn 31, Issue 3, 2011, Pages 913-920

  Ariad, Samuel ^a,b   Milk, Nadav ^b   Bolotin, Arkady ^b   Gopas, Jacob ^a,b   Sion Vardy, Netta ^a,b   Benharoch, Daniel ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Age; Breast cancer; Grade; Immunohistochemistry; Measles virus; p53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; HEMAGGLUTININ; HORMONE RECEPTOR; MEASLES ANTIGEN; MONOCLONAL ANTIBODY KI 67; NUCLEOPROTEIN; PROGESTERONE; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEASLES VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

ANTIGENS, VIRAL; BREAST NEOPLASMS; DEMOGRAPHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MEASLES VIRUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEPTORS, ESTROGEN; STAINING AND LABELING;

EID: 79956121829     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer Statistics 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Jatoi I, Anderson WF and Rosenberg PS: Qualitative age-interactions in breast cancer: a tale of two diseases? Am J Clin Oncol 31: 504-506, 2008.
3. Martin AM and Weber BL: Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92: 1126-1135, 2000.
4. Yager JD and Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270-282, 2006.
5. Amarante MK and Watanabe MA: The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol 135: 329-337, 2009.
6. Lawson JS: Do viruses cause breast cancer? Meth Mol Biol 471: 421-438, 2009.
7. Glaser SL, Hsu JL and Gulley ML: Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev 13: 688-697, 2004. (Pubitemid 38737855)
8. Frank O, Verbeke C, Schwarz N, Mayer J, Fabarius A, Hehlmann R, Leib-Mösch C and Seifarth W: Variable transcriptional activity of endogenous retroviruses in human breast cancer. J Virol 82: 1808-1818, 2008.
9. Fukuoka H, Moriuchi M, Yano H, Nagayasu T and Moriuchi H: No association of mouse mammary tumor virus-related retrovirus with Japanese cases of breast cancer. J Med Virol 80: 1447-1451, 2008. (Pubitemid 351897418)
10. de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R and Sastre-Garau X: No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 109: 55-58, 2008. (Pubitemid 351538756)
11. Mendizabal-Ruiz AP, Morales JA, Ramírez-Jirano LJ, Padilla-Rosas M, Morán-Moguel MC and Montoya-Fuentes H: Low frquency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 114: 189-194, 2009.
12. Benharroch D, Shemer-Avni Y, Myint YY, Levy A, Mejirovsky E, Suprun I, Shendler Y, Prinsloo I, Ariad S, Rager-Zisman B, Sacks M and Gopas J: Measles virus: evidence of an association with Hodgkin's disease. Br J Cancer 91: 572-579, 2004. (Pubitemid 39093581)
13. Ariad S, Lipshitz I, Benharroch D, Gopas J and Barchana M: A sharp rise in the incidence of Hodgkin's lymphoma in young adults in Israel. Isr Med Assoc J 11: 453-455, 2009.
14. Tarabeia J, Baron-Epel O, Barchana M, Liphshitz I, Ifrah A, Fishier Y and Green MS: A comparison of trends in incidence and mortality rates of breast cancer, incidence to mortality ratio and stage at diagnosis between Arab and Jewish women in Israel, 1979-2002. Eur J Cancer Prev 16: 36-42, 2007.
15. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS and Greene FL: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628-3636, 2002. (Pubitemid 34983222)
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds.): AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, pp. 347-376, 2010.
17. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1997.
18. Birrer MJ, Bloom BR and Udem S: Characterization of measles polypeptides by monoclonal antibodies. Virology 108: 381-390, 1981. (Pubitemid 11188844)
19. Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R and Slamon DJ: Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 18: 3651-3664, 2000.
20. Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N and Perou CM: Breast carcinomas arising at a young age: Unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 29: e18-e20, 2011.
21. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO and Botstein D: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
22. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R et al: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557, 1983. (Pubitemid 13018271)
23. Helfand RF, Kim DK, Gary HE Jr., Edwards GL, Bisson GP, Papania MJ, Heath JL, Schaff DL, Bellini WJ, Redd SC and Anderson LJ: Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol 56: 337-341, 1998. (Pubitemid 28516602)
24. Sonoda S, Kitahara M and Nakayama T: Detection of measles virus genome in bone-marrow aspirates from adults. J Gen Virol 83: 2485-2488, 2002.
25. Katayama Y, Kohso K, Nishimura A, Tatsuno Y, Homma M and Hotta H: Detection of measles virus mRNA from autopsied human tissues. J Clin Microbiol 36: 299-301, 1998. (Pubitemid 28047485)
26. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R and Benchimol S: PIRH2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112: 779-791, 2003. (Pubitemid 36378882)
27. Chen M, Cortay JC, Logan IR, Sapountzi V, Robson CN and Gerlier D: Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein. J Virol 79: 11824-11836, 2005. (Pubitemid 41279300)
28. zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698, 2000.
29. Hwang ES, Zhang Z, Cai H, Huang DY, Huong SM, Cha CY and Huang ES: Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein. J Virol 83: 12388-12398, 2009.
30. Gopas J, Itzhaky D, Segev Y, Salzberg S, Trink B, Isakov N, Rager-Zisman B: Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells. Cancer Immunol Immunother 34: 313-320, 1992.